Moderna
OrganizationHeard in 97 episodes across 30 shows since Jun 2026
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. The company's technology platform inserts synthetic nucleoside-modified messenger RNA (mRNA) into human cells to trigger immune responses.
Episodes
This week
Expert statements
Share of the conversation
Mentions of Moderna per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Aug 18 | 0.13‰ | 1 |
| Aug 19 | 0.57‰ | 14 |
| Aug 20 | 1.10‰ | 17 |
| Aug 21 | 1.48‰ | 10 |
| Aug 22 | 1.50‰ | 1 |
| Aug 23 | 1.57‰ | 2 |
| Aug 24 | 1.65‰ | 2 |
| Aug 25 | 1.68‰ | 2 |
| Aug 26 | 1.36‰ | 6 |
| Aug 27 | 0.83‰ | 1 |
| Aug 28 | 0.74‰ | 8 |
| Aug 29 | 0.76‰ | 2 |
| Aug 30 | 0.74‰ | 2 |
| Sep 2 | 0.48‰ | 2 |
| Sep 3 | 0.52‰ | 3 |
| Sep 12 | 0.03‰ | 1 |
| Sep 13 | 0.07‰ | 1 |
| Sep 14 | 0.09‰ | 1 |
| Sep 17 | 0.11‰ | 1 |
| Sep 18 | 0.14‰ | 1 |
| Sep 22 | 0.08‰ | 1 |
| Sep 25 | 0.08‰ | 2 |
| Sep 27 | 0.11‰ | 1 |
| Sep 28 | 0.19‰ | 3 |
| Sep 30 | 0.29‰ | 5 |
| Oct 1 | 0.35‰ | 2 |
| Oct 2 | 0.33‰ | 1 |
| Oct 4 | 0.33‰ | 1 |
| Oct 6 | 0.30‰ | 2 |
| Oct 7 | 0.22‰ | 2 |
What experts have said about Moderna
31 statements · 24 positive · 6 negative · 1 mixed
Moderna shares fell 7.7%.
“vaccine stocks unfortunately down uh 7.7 for moderna”
Open the episode · Constellation Brands Drops, Seagate Slides, Biotech FallsListen at 4:20
Concerns about plague in Russia contributed to Moderna’s decline.
“the concerns about the plague in russia”
Open the episode · Constellation Brands Drops, Seagate Slides, Biotech FallsListen at 4:28
Moderna shares have risen more than 500% this year.
“It has rallied more than 500% this year”
Open the episode · Accenture Gains, Synopsys Rises, Moderna Tumbles as Citi Advises Selling Following 600% RallyListen at 2:38
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
97 episodes featuring Moderna, newest first
- Oct 7, 2026
AI Safety Collides With the Race for SuperintelligenceMoonshots with Peter DiamandisOct 7, 2026 - Oct 7, 2026
Micron gains as SpaceX financing raises chip-demand questionsStock MoversOct 7, 2026 - Oct 6, 2026
AI rally lifts NVIDIA as nuclear power deal boosts ConstellationStock MoversOct 6, 2026 - Oct 6, 2026
Stocks slide as urban planners rethink smarter citiesStock MoversOct 6, 2026 - Oct 4, 2026
COVID reformers confront institutional resistance and vaccine accountabilityDarkHorse Podcast: The Evolutionary LensOct 4, 2026 - Oct 2, 2026
Nike stumbles as AI chips and index changes reshape marketsStock MoversOct 2, 2026